Gasser Elizabeth Anne 4
4 · TANDEM DIABETES CARE INC · Filed Feb 19, 2026
Research Summary
AI-generated summary of this filing
Tandem Diabetes (TNDM) EVP Elizabeth Gasser Receives RSUs
What Happened
Elizabeth A. Gasser, EVP and Chief Strategy Officer of Tandem Diabetes Care (TNDM), had restricted stock units (RSUs) convert into 2,600 shares on Feb 17, 2026. The company withheld 1,534 shares to satisfy tax withholding (valued at $18.95 each, totaling $29,070), leaving a net delivery of 1,066 shares to Gasser. No shares were sold on the open market.
Key Details
- Transaction date: 2026-02-17; Form 4 filed 2026-02-19 (filed within the normal 2-business-day window).
- Conversion (code M): 1,503 and 1,097 RSUs converted into shares (gross = 2,600).
- Tax withholding (code F): 887 and 647 shares withheld at $18.95/share = $16,809 and $12,261 (total $29,070).
- Net shares delivered to insider: 2,600 − 1,534 = 1,066 shares.
- Footnotes: Withholding was done by Tandem to satisfy tax obligations (no open-market sale). RSUs were awarded under the 2023 Long-Term Incentive Plan (awards from 2023 and 2024) and each RSU converts to one share (or cash at the company’s discretion). Some securities are held by The Gasser Family Trust, of which she is a co‑trustee. Vesting schedules per the awards: 33% on a specified date, remainder in quarterly installments (see filing footnotes).
- Shares owned after the transaction: Not specified in the provided excerpt of the filing.
Context
This was a routine RSU vesting event rather than an open-market purchase or sale. The M code reflects conversion of RSUs into shares; the F code reflects shares withheld by the company to cover tax withholding (common practice). Because no open-market sale occurred, this transaction does not indicate a directional buy/sell decision by the insider.
Insider Transaction Report
- Exercise/Conversion
Common Stock
2026-02-17+1,503→ 1,503 total - Tax Payment
Common Stock
[F1]2026-02-17$18.95/sh−887$16,809→ 616 total - Exercise/Conversion
Common Stock
2026-02-17+1,097→ 1,713 total - Tax Payment
Common Stock
[F1]2026-02-17$18.95/sh−647$12,261→ 1,066 total - Exercise/Conversion
Restricted Stock Unit
[F3][F4][F5]2026-02-17−1,503→ 1,503 total→ Common Stock (1,503 underlying) - Exercise/Conversion
Restricted Stock Unit
[F6][F4][F7]2026-02-17−1,097→ 5,484 total→ Common Stock (1,097 underlying)
- 25,949(indirect: See Footnote)
Common Stock
[F2]
Footnotes (7)
- [F1]Shares withheld by Tandem Diabetes Care Inc. (the Company) to satisfy tax withholding requirements on vesting of restricted stock units (RSU). No shares were sold.
- [F2]The securities are held by The Gasser Family Trust dated September 1, 2011, of which Elizabeth A. Gasser is a co-trustee.
- [F3]Awarded on May 25, 2023 pursuant to the Tandem Diabetes Care Inc. 2023 Long-Term Incentive Plan, as amended, and agreements related thereto (the 2023 Plan).
- [F4]Each RSU represents a contingent right to receive either one share of common stock of the Issuer or cash in lieu thereof, at the Issuer's discretion, in accordance with the terms of the 2023 Plan.
- [F5]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2024, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.
- [F6]Awarded on May 23, 2024 pursuant to the 2023 Plan.
- [F7]RSU vest as to thirty-three percent (33%) of the total number of shares subject to the RSU on 5/15/2025, and the remaining shares shall vest in eight (8) equal quarterly installments thereafter.